SSTR2 and meningioma: With nearly 100% of meningioma cells expressing somatostatin-2-receptors (SSTR2) on their surface, meningioma can be excellently targeted by radio-labeled SSTR compounds, such as 68-gallium labeled SSTR-agonists for PET imaging [3,4].